Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Astria Therapeutics, Inc. (ATXS)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Operating activities          
Net loss  -49.0-47.7-51.8-48.1-43.9-40.2-194.9-194.4
   
Reconciliation of net loss to net cash used in operating activities:          
    Stock-based compensation expense  4.84.64.64.54.34.23.42.7
    Right-of-use asset - operating lease  0.30.1      
    Other non-cash items  0.00.20.10.10.1-0.10.00.0
    Changes in assets and liabilities:          
        Prepaid expenses and other assets  -2.0-2.6-1.60.7-0.7-0.50.10.0
        Lease liability - operating lease  -0.3-0.2  -0.7-0.7  
        Accounts payable  -0.20.0 0.20.4-0.9-2.0-2.8
        Accrued expenses  1.51.34.41.50.91.9-1.3-1.7
            Net cash used in operating activities  -44.9-44.2-43.5-39.2-36.7-34.0-30.2-31.9
   
Investing activities          
Purchases of short-term investments  -534.1-410.3-396.1-295.6-242.9-159.7-78.0 
Sales and maturities of short-term investments  538.0465.3229.0224.7170.093.659.0 
Purchases of property and equipment   -0.1-0.1-0.10.0   
    Net cash provided by (used in) investing activities  3.855.0-167.1-70.9-72.9-66.1-12.6 
   
Financing activities          
Proceeds from exercise of stock options  0.40.10.10.1  0.00.0
    Net cash provided by financing activities  145.0144.8144.724.3  104.3104.3
    Net increase (decrease) in cash, cash equivalents and restricted cash  113.4164.9  -56.5-39.7  
   
Supplemental disclosure of non-cash transactions:          
    Conversion of Series X Preferred Stock into common stock   1.1      

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy